791 A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with relapsed or refractory classic hodgkin lymphoma (cHL)

by Hui Zhou, Jun Zhu, Xiaoling Li, Fei Li, Lei Fan, Lihong Liu, Zheng Zhao, Bing Chen, Qingyuan Zhang, Yuqin Song, Keshu Zhou, Chuan Jin, Zhengzi Qian, Ming Hou, Kaiyang Ding, Xiuhua Sun, Xianmin Song, Ming Jiang, Yu Hu, Ligen Liu, Hongwei Xue, Jun Luo, Bai He, Maxwell Wang
Published 2020-11-01

PPM1K Regulates Hematopoiesis and Leukemogenesis through CDC20-Mediated Ubiquitination of MEIS1 and p21

by Xiaoye Liu, Feifei Zhang, Yaping Zhang, Xie Li, Chiqi Chen, Meiyi Zhou, Zhuo Yu, Yunxia Liu, Yuzheng Zhao, Xiaoxin Hao, Yabin Tang, Liang Zhu, Ligen Liu, Li Xie, Hao Gu, Hongfang Shao, Fangzhen Xia, Chunrong Yin, Minfang Tao, Jingjing Xie, Cheng Cheng Zhang, Yi Yang, Haipeng Sun, Guo-Qiang Chen, Junke Zheng
Published 2018-05-01